Condition: Gastric Cancer · Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Multicentric, exploratory, non-pharmacologic, retrospective/prospective, translational study aiming to identify the molecular, cellular and psychological-sociological variables predictive of response to chemotherapy in gastric cancer patients.
This description comes directly from the study's public registry record.
Chiara Molinari · chiara.molinari@irst.emr.it
Chiara Zingaretti · cc.ubsc@irst.emr.it
Always discuss trial participation with your own doctor first.
| Centre Hospitalier Regional et Universitaire (CHRU) | Brest, France | Not Yet Recruiting |
| INSERM, Faculty of Medicine (UMR1078) | Brest, France | Active Not Recruiting |
| 1st Department of Propaedeutic Surgery, National & Kapodistrian University of Athens (NKUA) | Athens, Greece | Not Yet Recruiting |
| IRST IRCCS UO Oncologia | Meldola, Italy | Recruiting |
| AUSL Romagna, UO Oncologia | Ravenna, Italy | Active Not Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04842916